What is the role of Benzonatate (Tesalon) in asthma management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Guidelines

Benzonatate is not recommended for the treatment of asthma. This medication is primarily used as an antitussive (cough suppressant) and works by numbing stretch receptors in the lungs, which helps reduce the cough reflex. While benzonatate (typically dosed at 100-200 mg three times daily) is effective for managing coughs associated with various conditions, it has no bronchodilatory, anti-inflammatory, or other therapeutic effects that would benefit asthma pathophysiology.

Key Points to Consider

  • For asthma management, appropriate medications include:
    • Inhaled corticosteroids (like fluticasone, budesonide)
    • Bronchodilators (such as albuterol, salmeterol)
    • Leukotriene modifiers (montelukast), which directly address the underlying airway inflammation and bronchoconstriction characteristic of asthma 1, 2.
  • Using benzonatate in asthma patients might actually be counterproductive, as suppressing cough could potentially mask worsening symptoms that would otherwise alert patients to seek appropriate asthma treatment.
  • If a patient with asthma has a problematic cough despite optimal asthma management, the focus should be on improving asthma control rather than adding a cough suppressant like benzonatate.

Evidence-Based Recommendations

The most recent and highest quality studies support the use of inhaled corticosteroids, bronchodilators, and leukotriene modifiers for asthma management, with no evidence to support the use of benzonatate for this condition 1, 2.

Clinical Implications

In clinical practice, the use of benzonatate for asthma would not be recommended due to its lack of therapeutic effects on asthma pathophysiology and the potential for masking worsening symptoms 3. Instead, healthcare providers should focus on optimizing asthma control with evidence-based medications.

From the FDA Drug Label

BENZONATATE acts peripherally by anesthetizing the stretch receptors located in the respiratory passages, lungs, and pleura by dampening their activity and thereby reducing the cough reflex at its source. BENZONATATE has no inhibitory effect on the respiratory center in recommended dosage. BENZONATATE is indicated for the symptomatic relief of cough.

The use of benzonatate in asthma is not directly addressed in the provided drug labels. However, based on the information that benzonatate is indicated for the symptomatic relief of cough 4 and it acts by reducing the cough reflex at its source 4, it may be considered for use in asthma patients with cough symptoms.

  • Key points:
    • Benzonatate reduces the cough reflex.
    • Benzonatate is indicated for symptomatic relief of cough. However, benzonatate's effect on asthma itself, beyond cough relief, is not explicitly stated in the labels 4 4.

From the Research

Asthma Treatment Overview

  • Asthma is a heterogeneous clinical syndrome primarily affecting the lower respiratory tract, characterized by episodic or persistent symptoms of wheezing, dyspnea, and cough 5
  • The diagnosis of asthma requires these symptoms and demonstration of reversible airway obstruction using spirometry
  • Identifying clinically important allergen sensitivities is useful in managing asthma

Benzonatate in Asthma

  • There is no direct mention of Benzonatate in the provided studies as a treatment for asthma
  • However, the studies discuss various treatments for asthma, including inhaled corticosteroids, long-acting β2-agonists, and combination therapies 5, 6, 7, 8, 9

Alternative Treatments for Asthma

  • Inhaled corticosteroids and long-acting β2-agonists are recommended treatment options for asthma 6
  • Combination therapies, such as fluticasone/salmeterol and budesonide/formoterol, are effective in improving lung function and symptom control in patients with asthma 6, 7, 8, 9
  • Other controller approaches include long-acting muscarinic antagonists and biological agents directed against proteins involved in the pathogenesis of asthma 5

Comparison of Asthma Treatments

  • Studies have compared the effectiveness of different combination therapies, such as budesonide/formoterol and fluticasone/salmeterol, in reducing asthma exacerbations and improving symptom control 7, 8, 9
  • The results suggest that budesonide/formoterol may be more effective in reducing asthma exacerbations and improving symptom control compared to fluticasone/salmeterol 7, 9

Related Questions

What are the effects of asthma on ventilation, perfusion, airway (Airway) resistance, lung compliance, minute ventilation, and arterial blood gas (ABG) parameters, including partial pressure of carbon dioxide (pCO2) and partial pressure of oxygen (pO2)?
In an adult with persistent asthma and no contraindications, how do fluticasone and budesonide compare as the inhaled corticosteroid component of a long‑acting beta‑agonist/inhaled corticosteroid (LABA/ICS) combination?
What inhaler regimen upgrade would you recommend for a 36-year-old woman with poorly controlled asthma who is currently using fluticasone/formoterol 100 µg/6 µg per actuation and salbutamol as needed?
What is the most appropriate immediate management for a 39-year-old woman with hypothyroidism and moderate persistent asthma who presents after eating lunch with oral itching, wheezing, hives, nausea, shortness of breath, and faint expiratory wheezing but no oropharyngeal swelling?
A 36-year-old male with asthma previously well controlled on Trelegy (fluticasone furoate/umeclidinium/vilanterol) 100/62.5 µg daily now has worsening symptoms; how should his management be adjusted?
Which electrocardiogram (ECG) leads are optimal for ST segment monitoring?
What constitutes an acute kidney injury (AKI) emergency?
What is the wavelength of the Wood's (Wood's ultraviolet) lamp?
What are the treatment options for ocular rosacea?
What differentiates necrotizing fasciitis from other conditions?
What are the symptoms of hypokalemia (potassium level of 2.9)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.